Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on Lu AG06466 PK in Healthy Volunteers
NCT04405323Phase 1Completed
- Sponsor
- Lundbeck
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ABX-1431 in Tourette syndrome (TS), post-traumatic stress disorder (PTSD) and multiple sclerosis (MS) (2 arms), sponsored by Lundbeck. Primary endpoints: Area Under the Curve (AUC0-inf) of Lu AG06466, Area Under the Curve (AUC0-inf) of Lu AG06988 and 2 more. Started May 2020; status: completed.
02
Drugs
ABX-1431
03
Conditions
Tourette syndrome (TS)post-traumatic stress disorder (PTSD)multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04405323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04405323.